Svetlana Shechtman
Overview
Explore the profile of Svetlana Shechtman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
533
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Richardson J, Moore A, Stellfeld M, Geissbuhler Y, Winterfeld U, Favre G, et al.
Drug Saf
. 2025 Feb;
PMID: 39907983
Background And Objective: Standardised procedures for performing and reporting safety monitoring studies investigating medications use in pregnancy may help improve data quality and the speed of data generation. The objective...
2.
Damkier P, Gram E, Ceulemans M, Panchaud A, Cleary B, Chambers C, et al.
Obstet Gynecol
. 2024 Dec;
145(2):168-176.
PMID: 39637384
Acetaminophen is a common over-the-counter medication that recently gained substantial media attention regarding its use by pregnant individuals. In this clinical perspective, we discuss the strengths and limitations of the...
3.
Damkier P, Shechtman S, Diav-Citrin O, Panchaud A, Weber-Schoendorfer C, Hodson K, et al.
Pharmacoepidemiol Drug Saf
. 2024 Oct;
33(10):e70016.
PMID: 39420753
No abstract available.
4.
Garey J, Damkier P, Scialli A, Lusskin S, Braddock S, Chouchana L, et al.
Birth Defects Res
. 2024 Aug;
116(8):e2392.
PMID: 39189597
On January 12, 2024 the safety committee of the European Medicines Agency (EMA) recommended precautionary measures over a potential risk of neurodevelopmental disorders in children born to men treated with...
5.
Dao K, Shechtman S, Weber-Schoendorfer C, Diav-Citrin O, Murad R, Berlin M, et al.
BMJ Open
. 2024 Apr;
14(4):e083550.
PMID: 38663923
Objectives: Glucagon-like peptide 1 receptor agonists (GLP1-RA) are indicated for the treatment of type 2 diabetes and more recently for weight loss. The aim of this study was to assess...
6.
Favre G, Richardson J, Moore A, Geissbuhler Y, Jehl V, Oliver A, et al.
Drug Saf
. 2023 Dec;
47(3):227-236.
PMID: 38114757
Introduction And Objective: The ConcePTION project aims to improve the way medication use during pregnancy is studied. This includes exploring the possibility of developing a distributed data processing and analysis...
7.
Dao K, Shechtman S, Diav-Citrin O, George N, Richardson J, Rollason V, et al.
J Clin Psychopharmacol
. 2022 Dec;
43(1):12-19.
PMID: 36584245
Purpose/background: Trazodone is indicated for the treatment of major depressive disorder, but more frequently prescribed off-label at lower doses for insomnia in women of childbearing age. The aim of this...
8.
Panchaud A, Cleary B, Weber-Schoendorfer C, Shechtman S, Cassina M, Diav-Citrin O, et al.
J Clin Epidemiol
. 2022 Oct;
152:125-126.
PMID: 36223814
No abstract available.
9.
Damkier P, Cleary B, Weber-Schoendorfer C, Shechtman S, Cassina M, Panchaud A, et al.
Nat Rev Endocrinol
. 2021 Dec;
18(3):191.
PMID: 34907340
No abstract available.
10.
Damkier P, Kaplan Y, Shechtman S, Diav-Citrin O, Cassina M, Weber-Schoendorfer C
Basic Clin Pharmacol Toxicol
. 2020 Dec;
128(4):579-582.
PMID: 33275828
Ondansetron is an effective antiemetic that is being widely used as a second-line treatment option for severe nausea and vomiting of pregnancy in accordance with clinical guidelines. The safety of...